</SEC-HEADER>
<SEQUENCE>1


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 10-QSB
                                  -----------

                                   (Mark One)

     [X] QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES
                             EXCHANGE ACT OF 1934.

                 For the quarterly period ended March 31, 2008

    [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
                             EXCHANGE ACT OF 1934.

            For the transition period from __________ to __________

                        Commission File Number 000-9519

                            REGENT TECHNOLOGIES, INC.
                      ------------------------------------

       (Exact name of small business issuer as specified in its charter)


             COLORADO                                    84-0807913
     -------------------------------                  -------------------
     (State or other jurisdiction of                   (I.R.S. Employer
     incorporation or organization)                   Identification No.)


                          6727 Hillcrest Ave., Suite E
                              Dallas, Texas 75205
                    (Address of principal executive offices)

                                  214-507-9507
                          (Issuer's telephone number)

                         Regent Petroleum Corporation
                            (Former name of Issuer)

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or
for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.

Yes [ ] No [X]

The number of outstanding shares of the issuer's only class of common stock as
of May 1, 2008 was 5,657,456.

Transitional Small Business Disclosure Format (check one):

Yes [ ] No [X]

Shell Company (check one):

Yes [X] No [ ]





<PAGE>
                             REGENT TECHNOLOGIES, INC.
                          (A DEVELOPMENT STAGE COMPANY)

                              INDEX TO FORM 10-QSB

                                 MARCH 31, 2008

                                                                       Page Nos.
                                                                       --------

PART I - FINANCIAL INFORMATION

  ITEM 1 - FINANCIAL STATEMENTS

    BALANCE SHEET (UNAUDITED)                                                 2
      At March 31, 2008

    STATEMENTS OF OPERATIONS (UNAUDITED)                                      3
      For the Three Months Ended March 31, 2008 and 2007
      For the Period from Inception (January 1, 1999) to
        March 31, 2008

    STATEMENTS OF CASH FLOWS (UNAUDITED)                                      4
      For the Three Months Ended March 31, 2008 and 2007
      For the Period from Inception (January 1, 1999) to
        March 31, 2008

    NOTES TO FINANCIAL STATEMENTS (UNAUDITED)                               5-8

  ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION       8-10

  ITEM 3 - CONTROLS AND PROCEDURES                                           10

PART II - OTHER INFORMATION

  ITEM 1 - LEGAL PROCEEDINGS                                                 11

  ITEM 1A - RISK FACTORS                                                     11

  ITEM 2 - CHANGES IN SECURITIES AND PURCHASES OF EQUITY SECURITIES          11

  ITEM 3 - DEFAULTS UPON SENIOR SECURITIES                                   11

  ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS               11

  ITEM 5 - OTHER INFORMATION                                                 11

  ITEM 6 - EXHIBITS AND REPORTS ON FORM 8-K                                  12

  SIGNATURES AND REQUIRED CERTIFICATIONS                                     12


                                       1
<PAGE>

                                    PART I

ITEM 1 - FINANCIAL STATEMENTS

                    REGENT TECHNOLOGIES, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                           CONSOLIDATED BALANCE SHEET
                                 MARCH 31, 2008
                                  (UNAUDITED)

<TABLE>
<CAPTION>

<S>                                                                      <C>
                                     ASSETS

CURRENT ASSETS
  Cash in bank                                                          $   47,212
  Settlements and receivable, net of $12,892
     allowance for uncollectible accounts                                        -
                                                                          ---------
Total Current Assets                                                        47,212

Property and equipment:
   Furniture and fixtures                                                    8,593
   Computer equipment                                                        2,400
                                                                         ---------
                                                                            10,993
   Less accumulated depreciation                                           (10,993)
                                                                         ---------

     Net property and equipment                                                  -

Investments in affiliate (Note 3)                                          328,081
                                                                         ---------
TOTAL ASSETS                                                            $  375,293
                                                                         =========


                 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES
   Accounts payable, trade                                              $   32,712
   Accounts payable, stockholder                                            10,000
   Note payable, related parties                                            18,520
   Accrued interest payable                                                    312
                                                                         ---------
      Total Current Liabilities                                             61,544
                                                                         ---------

STOCKHOLDERS' EQUITY (DEFICIT)
   Preferred stock, $.10 par value, 1,000,000
     shares authorized, 75,000 shares issued and
     outstanding, Regent GLSC Technologies, Inc.                           375,000
   Preferred stock, $.10 par value, 30,000,000
     shares authorized, no shares issued and
     outstanding, Registrant                                                     -
   Common stock, $.01 par value, 100,000,000
     shares authorized, 5,657,456 shares
     issued and outstanding                                                 56,575
   Paid-in capital in excess of par                                      3,351,545
   Accumulated deficit (including $121,372
     accumulated since reentering the development stage)                (3,469,371)
                                                                         ---------
     						                           313,749
                                                                          ---------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                    $  375,293
                                                                          =========


 The accompanying notes are an integral part of the consolidated financial statements.

</TABLE>

                                       2
<PAGE>

                     REGENT TECHNOLOGIES, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                       CONSOLIDATED STATEMENTS OF OPERATIONS
                FOR THE THREE MONTHS ENDED MARCH 31, 2008 AND 2007
                       AND FOR THE PERIOD JANUARY 1, 1999
                            THROUGH MARCH 31, 2008
                                  (UNAUDITED)
<TABLE>
<CAPTION>
						  		   		         Cumulative
                                                                                     Since Re-entering
                                              For the Three Months Ended March 31,   Development Stage
                                                     2008               2007          January 1, 1999
                                                ------------        ------------        ------------
<S>                                            <C>                 <C>                 <C>
Revenues                                          $       -          $       -           $       -

Operating expenses:


  General and administrative                         14,069              17,369             286,706
  Interest                                            1,036               1,692              35,433
                                                   ---------           ---------           ---------
Operating loss                                     ( 15,105)           ( 19,061)           (322,139)
                                                   ---------           ---------           ---------

Gain on extinguishment of debt                            -                   -             124,186
Gain on sale of investment                           35,125                   -              76,581
                                                   ---------           ---------           ---------
Income (Loss) before income taxes                    20,020              19,061            (121,372)

Provisions for income taxes                               -                   -                   -
                                                  ---------           ---------           ---------
Net income (loss)                                 $  20,020           $  19,061           $(121,372)
                                                  =========           =========           =========

Net income (loss) per common share:               $     .00           $     .00
                                                  =========           =========

Weighted average shareS outstanding               5,657,456           4,806,483
                                                  =========           =========


  The accompanying notes are an integral part of the consolidated financial statements.


</TABLE>

                                       3
<PAGE>
                     REGENT TECHNOLOGIES, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                 FOR THE THREE MONTHS ENDED MARCH 31, 2008 AND 2007
                       AND FOR THE PERIOD JANUARY 1, 1999
                            THROUGH MARCH 31, 2008
                                  (UNAUDITED)
<TABLE>
<CAPTION>
						  		   		                    Cumulative
                                                                                                 Since Re-entering
                                                          For the Three Months Ended March 31,   Development Stage
                                                                 2008               2007          January 1, 1999
                                                             ------------       ------------        ------------
<S>                                                           <C>                 <C>                 <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net income (loss)                                           $  20,020           $ (19,061)         $ (121,372)
  Adjustments to reconcile net income (loss) to net
   cash used in operating activities:
     Depreciation                                                     -                   -               3,762
     Gain from extinguishment of accounts payable                     -                   -            (124,186)
     Gain from sale of investment                              ( 35,125)                  -            ( 76,581)
     Note issued for settlement expenses                              -                   -              20,000
     Common stock issued for services                                 -                   -              13,472
     Common stock issued in legal settlement                          -                   -              14,000
     Decrease in settlements and note receivable                      -                   -               4,800
     Decrease in other assets                                         -                   -               1,967
     Increase in allowance for uncollectible settlements              -                   -              79,892
     Increase (decrease) in accounts payable                   (  3,458)              9,669              42,890
     Increase (decrease) in accounts payable, stockholder             -                   -              10,000
     Increase in accrued liabilities                           (  7,965)             76,692              35,048
                                                              ---------           ---------           ---------
        Net Cash Used In Operating Activities                  ( 26,528)             67,300            ( 96,308)
                                                              ---------           ---------           ---------
CASH FLOWS FROM INVESTING ACTIVITIES:
  Investment in affiliates                                            -                  -             (350,000)
                                                              ---------           ---------            ---------
        Net Cash Used in Investing Activities                         -                  -             (350,000)

CASH FLOWS FROM FINANCING ACTIVITIES:

  Proceeds from sale of Preferred Stock                          50,000                   -             375,000
  Proceeds from sale of investments                             100,000                                 100,000
  Increase (decrease) notes payable - related party            ( 76,280)             15,000              18,520
                                                              ---------           ---------           ---------
        Net Cash Provided By Financing Activities                73,720              15,000             493,520
                                                              ---------           ---------           ---------
Net Increase (Decrease) in Cash                                  47,192              82,300              47,212

Cash At Beginning Of Period                                          20                 175                   -
                                                              ---------           ---------           ---------
Cash At End of Period                                         $  47,212           $  82,475           $  47,212
                                                              =========           =========           =========


                      SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
                      --------------------------------------------------------------------

    Issuance of common stock upon conversion
    of notes payable                                          $       -           $       -           $ 193,840

    Common stock issued for director stock awards             $       -           $       -           $  13,472

    Common stock returned in failed consideration
    and debt settlement                                       $       -           $       -           $ 509,760

    Repayment of note payable transferred directly
    to MacuCLEAR upon sale to GHI, Ltd.                       $       -           $       -           $ 150,000

    Partial sale of MacuCLEAR holdings to GHI, Ltd.           $       -           $       -           $ 148,500

    Issuance of common stock upon MacuCLEAR sale
    to GHI, Ltd.                                              $       -           $       -           $   1,500



The accompanying notes are an integral part of the consolidated financial statements.

</TABLE>

                                        4
<PAGE>

                     REGENT TECHNOLOGIES, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
               NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

1.  DESCRIPTION OF THE BUSINESS:

Regent  Technologies, Inc., (the Company) formerly Regent Petroleum Corporation,
was incorporated on January 18, 1980, in the state of Colorado for the purpose
of exploration  and development of oil and gas properties in the United States.
Activities of the Company up to 1992 were primarily organizational and included
the issuance of equity capital and the acquisition of developed and undeveloped
oil and gas properties that included the formation of Earth Minerals, Inc. in
1991, which was later renamed Regent Industries, Inc. In 1992, the Company
redirected its core activities and acquired SSB Environmental, Inc. (SSB), which
was organized for the purpose of obtaining waste and landfill reclamation
contracts. Effective January 1, 1996, the Company sold 100% of Regent Industries
and 81% of its interest in SSB.  In September, 1996, the Company entered into a
license agreement for the technologies necessary to offer dialup access to the
Internet. During the fourth quarter of 1996, the Company organized Regent TEL1
Communications, Inc. as a Nevada corporation and a wholly owned subsidiary to
market its Internet products and services primarily to consumer markets.  In the
third quarter of 1997, the Company acquired ConnecTen, L.L.C. as a wholly owned
subsidiary to market its dedicated Internet access services to professionals and
corporations.  During the first quarter of 1998,the Company acquired Channel
Services, LC, to expand its telecommunications products to include wireless
telephone services.  The acquisitions of ConnecTen and Channel Services were
accounted for under the purchase method of accounting.  During the first quarter
of 1998, the Company organized Regent Digital Imaging, Inc. to offer digital
printing and prepress services with access available via the Internet. Effective
January 1, 1998, the Company in the ordinary course of business divested 100%
of its ownership in all subsidiary companies and re-entered the development
stage.

Recent Business Developments

During the first quarter, 2007, the Registrant initiated a new business strategy
to create value for our stockholders by investing in business opportunities that
have a unique technological advantage.  Key elements of our business strategy
include  investing in  businesses with: (1) the potential of outstanding earning
power and  good  returns  on equity; (2) experienced  management; and (3) a
business plan which  demonstrates a high likelihood for success in a relatively
short period of time.  In March, 2007, the Company formed a Texas corporation as
a wholly owned subsidiary named Regent GLSC Technologies, Inc. ("Regent GLSC").
See ITEM 6 - Management's Discussion and Analysis for Plan of Operation" for
the details and status of the operations of Regent GLSC and other business
initiatives.

Going concern uncertainties

As of the date of this quarterly report, there is substantial doubt regarding
our ability to continue as a going concern as we have not generated sufficient
cash flow to fund our business operations and material commitments. Our future
success and  viability, therefore, are  dependent  upon our ability to generate
capital financing.  We are  optimistic  that we will be  successful in  our new
business  operations  and  capital  raising  efforts; however,  there can be no
assurance that we will be successful in generating revenue or raising additional
capital. The failure to generate sufficient revenues or raise additional capital
may have a material and adverse effect upon the Company and our shareholders.

These consolidated financial statements do not give effect to any adjustments
which would be necessary should the Company be unable to continue as a going
concern and therefore be required to realize its assets and discharge its
liabilities in other than the normal course of business and at amounts different
from those reflected in the accompanying consolidated financial statements.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The consolidated financial statements have been prepared in accordance with
the instructions to Form 10-QSB, but do not include all the information and
footnotes required by accounting principles generally accepted in the United
States of America for complete financial statements. These statements should
be read in conjunction with the consolidated financial statements and

                                        5
<PAGE>

                     REGENT TECHNOLOGIES, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
               NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


footnotes in the Company's annual report on Form 10-KSB for the year ended
December 31, 2007. Operating results for the three months ended
March 31, 2008 are not necessarily indicative of the results that may be
expected for the year ending December 31, 2008.

Development stage activities

By the end of 1998, the Company had ceased operations and had divested itself
of any interests in subsidiary companies and  effective January 1, 1999  had
re-entered the development stage.  Accordingly, all of the Company's operating
results and cash flows reported in the accompanying financial statements from
that date are considered to be those related to development  stage activities
and represent the 'cumulative  from inception' amounts  from  its development
stage activities  reported  pursuant to  Statements of  Financial  Accounting
Standards ("SFAS") No. 7, Accounting and Reporting by Development Stage
Enterprises.

Management estimates

To prepare financial statements in conformity with United States of America
generally accepted accounting principles, management makes estimates and
assumptions based on available information. These estimates and assumptions
affect the amounts reported in the financial statements and the disclosures
provided, and actual results could differ.  The allowance for loan losses,
fair values of financial investments and carrying value of intangible assets
are particularly subject to change.

Recent accounting pronouncements

In December 2007, the FASB issued Statement of Financial Accounting
Standards No. 141 (revised 2007) ("SFAS 141R"), Business Combinations,
and Statement of Financial Accounting Standards No. 160 ("SFAS 160"),
Noncontrolling Interests in Consolidated Financial Statements, an amendment
of Accounting Research Bulletin No. 51. SFAS 141R will change how business
acquisitions are accounted for and will impact financial statements both
on the acquisition date and in subsequent periods. SFAS 160 will change
the accounting and reporting for minority interests, which will be
recharacterized as noncontrolling interests and classified as a component
of equity. SFAS 141R and SFAS 160 are effective in 2009. The Company is
currently evaluating the impact that SFAS 141R and SFAS 160 will have on
its consolidated financial statements.

In September 2006, the FASB issued Statement of Financial Accounting
Standards No. 157 ("SFAS 157"), Fair Value Measurements, which defines
fair value, establishes guidelines for measuring fair value, and expands
disclosures regarding fair value measurements. SFAS 157 does not require
any new fair value measurements but rather eliminates inconsistencies
in guidance found in various prior accounting pronouncements. SFAS 157
is effective for fiscal years beginning after November 15, 2007. However,
in February 2008, the FASB issued FASB Staff Position FAS 157-2 ("FSP
FAS 157-2"), which delays the effective date of SFAS 157 for all
nonfinancial assets and nonfinancial liabilities, except those that are
recognized or disclosed at fair value in the financial statements on a
recurring basis (at least annually), until fiscal years beginning after
November 15, 2008 and interim periods within those fiscal years. As of
January 1, 2008, the Company has adopted SFAS 157 except as it applies
to those nonfinancial assets and nonfinancial liabilities as noted in
FSP FAS 157-2. The partial adoption of SFAS 157 does not have a material
impact on the Company's consolidated financial statements.

In February 2007, the FASB issued Statement No. 159, "The Fair Value Option
for Financial Assets and Financial Liabilities, including an amendment of
FASB Statement No. 115" ("SFAS 159").  SFAS 159 allows entities to choose to
measure certain financial instruments and certain other items at fair value.
The standard requires that unrealized gains and losses on items for which
the fair value option has been elected be reported in earnings.  SFAS 159 is
effective for fiscal years beginning after November 15, 2007.

Management is continuously assessing its adoption of SFAS 157 and SFAS 159,
and the effect, if any, on the Company's financial position or results of
operations.  Refer to Note 8 for disclosures required by these new
pronouncements.

                                        6
<PAGE>

                     REGENT TECHNOLOGIES, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
               NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

3.     INVESTMENTS IN AFFILIATES

MacuCLEAR, Inc. investment

On April 17, 2007, Regent GLSC executed a purchase agreement in the amount of
$1,000,000 for the acquisition of 385,356 shares of Series A 8% Preferred Stock
of MacuCLEAR, Inc. ("Preferred Stock"), convertible on a pro-rata, non-dilutable
basis into 20% of the common stock of MacuCLEAR for a period of 24 months after
closing.  Regent GLSC re-negotiated the purchase to 192,678 shares for $500,000.
The source of the payment was $300,000 from the sale of 60,000 shares of Regent
GLSC Series A Convertible Preferred Stock (Note 4) and $55,000 from NR Partners
(Note 6).  In addition, the Regent GLSC sold 41,250 shares of MacuCLEAR
Preferred Stock for $148,500 to complete the funding.

Partial sales of MacuCLEAR investment

On June 29, 2007, Regent GLSC sold  41,250 shares of MacuCLEAR Preferred Stock
for $3.60 per share to GHI, Ltd. and a gain of $41,456 was recognized.  In
consideration for this sale, GHI, Ltd. purchased 3,750 shares of restricted
common stock of the Registrant for $0.40 per share.

Effective March 7, 2008, Regent GLSC sold 25,000 shares of MacuCLEAR Preferred
stock for $100,000 and a gain of $35,125 was recognized for the current period.
As of the date of this quarterly filing, Regent GLSC holds title to 126,428
shares of MacuCLEAR Preferred Stock, of which 72,254 shares are beneficially
held for the holders of Regent GLSC Preferred Stock.

4.     CAPITAL STRUCTURE DISCLOSURES

Subsidiary Preferred Stock

On April 18, 2007, Regent GLSC accepted purchase agreements in a total amount
of $150,000.00 received from four purchasers of a private offering of shares
of Series A Convertible Preferred Stock ("Regent GLSC Preferred Stock").  Under
the accepted purchase agreements, the subscribers purchased through a Preferred
Stock Purchase Agreement 30,000 shares of Regent GLSC's Series A Convertible
Preferred Stock at $5.00 per share. The stock was sold under a private placement
offering to sell 25% of the equity of Regent GLSC for $1,250,000 in $50,000.00.
units.  Each unit is convertible into 10,000 shares of common stock of Regent
GLSC plus 0.5% of the outstanding shares of common stock of MacuCLEAR, non-
dilutable for a period of 24 months after closing.  Including the initial sales
on April 18, 2007, Regent GLSC has accepted Preferred Stock purchase agreements
from additional investors in the total amount of $375,000.00.  On February 20,
2008, Regent GLSC sold 10,000 shares of Regent GLSC Preferred Stock for $5.00
per share as the final sale under the initial private placement offering.

Common Stock

The Company's capital structure is complex and consists of preferred stock and
a general class of common stock. The Company is authorized to issue 130,000,000
shares of stock, 30,000,000 of which have been designated as preferred shares
with a par value per share of $.10, and 100,000,000 of which have been
designated as common shares with a par value per share of $.01.  As of this
report, 5,657,456 shares of common stock are outstanding.  This compares to
4,806,483 shares for the same period in 2007 with the difference due to
the sale of 3,750 common stock shares to GHI, Ltd. (Note 3) and the stock grant
awards (Note 6).  Of this amount, 120,000 shares will be cancelled as a result
of the summary judgment rendered in favor of the Company under Regent litigation
to reclaim the issuance of unauthorized shares of common stock of the Company
(Note 9).  The Company is scheduled to issue 50,000 shares of restricted
common stock as payment for legal fees associated with the litigation.

5.     NOTES PAYABLE

During the third quarter, 2005, the Company borrowed $22,100 under a note
payable to NR Partners, a partnership of which the President is a partner
and Director David Ramsour is a partner.  The note payable is a promissory
note for a maximum amount of $100,000 extended for payment to on or before
July 31, 2008 with interest at the rate of 8.5 percent. The funds were used
to pay expenses related to professional and transfer agent fees incurred
primarily to bring the Company current with its SEC filings.  During 2007,
the Company had additional borrowings under the note payable to help fund
the purchase of the MacuCLEAR Preferred Stock.  The total NR borrowings
outstanding at December 31, 2007 was $89,800.  On December 28, 2007, the
Company borrowed $5,000 under a promissory note to Director Phil Ralston,
which note is due and payable on or before December 31, 2008.  In February,
2008, the Company made payments toward the note of NR Partners totaling
$86,520.90 in principal and $8,760.01 in interest.

                                        7
<PAGE>

                     REGENT TECHNOLOGIES, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
               NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS

6.     STOCK-BASED COMPENSATION

The Company has outstanding restricted common stock grant awards issued
under its equity incentives for board members.  The Company granted
847,223 shares of restricted common stock in 2007.  See Note 3 to
the financial statements in the Company's Form 10-KSB for the year ended
December 31, 2007 for additional information. The Company accounts for
stock option grants and restricted stock awards in accordance with SFAS
No. 123(R), "Accounting for Stock-Based Compensation."

7.     RELATED PARTY TRANSACTIONS

During the current quarterly period, the Company made principal and interest
payments on the NR Partners promissory note held indirectly by David Nelson,
President, and Dr. David Ramsour, a Director (Note 5).

8.     FAIR VALUE MEASUREMENTS

Effective January 1, 2008, the Company adopted both SFAS 157 and SFAS 159
without any effect.

The Company determined that its cash and  non-cash investments, notably
its investment in MacuCLEAR Preferred Stock, are valued fairly for the
current period due to the the nominal sales of the Preferred Stock since
the date of issuance, April 17, 2007.

9.     SUBSEQUENT EVENTS

During May, 2008, the Company repaid the outstanding note payable in the
amount of $5,000 to Phil Ralston, a Director of the Company.

The Company received notification on May 16, 2008, that the Court had
rendered a default judgment in favor of Regent against the last defendant
in the case styled Leake v. Regent Technologies, Inc.  See PART II, ITEM 1
for additional information.

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

Forward-Looking Information

This Form 10-QSB contains forward-looking statements as referenced in the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
are subject to many risks and uncertainties.  When used herein, the terms
'anticipates,' 'plans,' 'expects,' 'believes,' and similar expressions as
they relate to the Company or its management are intended to identify such
forward looking statements.  Actual results could differ materially from
those indicated by the forward-looking statements. Risks and uncertainties
that could cause or contribute to differences include, changes in the
regulatory environment, changes in business conditions and inflation, risks
associated with credit quality and other factors discussed in the Company's
filings with the U.S. Securities and Exchange Commission, including its
Annual Report on Form 10-KSB for the year ended December 31, 2007. The
Company assumes no obligation to update any forward-looking statement.

Business

Regent Technologies, Inc., a Colorado corporation, currently trades on the
"pink sheets" under the symbol "REGT".  The Registrant ("Regent," "Company,"
"we," "our" or "us") is a technology-based company engaged in identifying and
developing emerging technologies.  The following discussion and analysis
should be read in conjunction with the remainder of this Quarterly Report
on Form 10-QSB including, but not limited to, the financial statements
and notes thereto included herein.

Plan of operation

As a development stage company, Regent has funded operations through short-term
borrowings and equity investments in order  to meet  obligations.  Our  future
operations are dependent  upon  external funding and our ability  to  increase
revenues and reduce expenses.  Management believes that sufficient funding will
be available from additional related party borrowings and private placements to
meet our business  objectives  including  anticipated cash  needs for  working
capital, for a reasonable period of time. In 2007, the Regent initiated a new
business strategy to create shareholder by investing in business opportunities
with a unique technological advantage.  Key elements of our business strategy
include  investing in  or acquiring businesses with:  (1) the potential of
outstanding earning power and  good  returns  on equity; (2) experienced
management; and (3) a business plan which  demonstrates a high likelihood for
success in a relatively short period of time.

                                       8
<PAGE>

Recent activities

During the first quarter, 2008, the Company has continued its review of the
development or co-development of new technologies through discussions with
companies holding technologies or technology licenses in the fields of energy
development, including renewable energy as well as the non-conventional
development of oil and gas resources.  In addition, the Company is in
discussions with an environmental services company with technologies in the
fields of environmental remediation and reclamation. On April 17, 2007, Regent
acquired its initial entry into the life science technology market with the
execution by its wholly owned subsidiary, Regent GLSC, of a stock purchase
agreement for 385,356 shares of 8% Convertible Preferred Stock of MacuCLEAR,
Inc. (Note 3.)

  About MacuCLEAR, Inc.

MacuCLEAR has the exclusive license for a platform technology for preventing the
progression of Age Related Macular Degeneration ("AMD") with the potential of
reversing the effect of AMD.  Specifically MacuCLEAR has licensed a proprietary
treatment for the "Dry" form of AMD.  The solution is delivered in eye drop form
to restore choroidal blood flow and control inflammation in the macula. The core
component of this novel solution has been used clinically in other applications
and is known to be safe.  Therefore, MacuCLEAR is eligible for an abbreviated
FDA approval process.

MacuCLEAR management met with the Ophthalmology Division of FDA's Center for
Drug Evaluation and Research on March 26, 2008. Twelve members of the FDA team,
including the Division head met with four members of the MacuCLEAR team. The
purpose of the meeting was to review a previously submitted briefing book and
to confirm the FDA's responses to questions submitted with this book. The
meeting outcome was positive.  MacuCLEAR intends to complete its IND
submission by mid July.

MacuCLEAR is headed by an executive team of business and life science
professionals with significant industry experience.  Philip G. Ralston is the
CEO of MacuCLEAR and the President of Regent GLSC.  He is a seasoned life
science industry professional with Fortune 200, and mid-size private and public
company experience.  He has started four companies and holds 18 patents on
various products.  David A. Nelson, Chief Executive Officer of Regent GLSC and
the Registrant, is a member of the Board of Directors of MacuCLEAR with
Mr. Ralston.

Financial Condition - Three months ended March 31, 2008 compared with
Three months ended March 31, 2007

Revenues

The Company had no sales for the quarterly periods ended March 31, 2008
and March 31, 2007.

Operating Expenses

Operating expenses primarily include general and administrative expenses,
litigation settlement expense and acquisition expenses related to MacuCLEAR.
General and administrative expenses were $14,069 for the three months ended
March 31, 2008 compared to $17,369 for the three months ended March 31, 2007.
The decrease in administrative expenses is the result of reduced expenses
relating to stock transfer agent and legal fees.  Interest expense was $1,036
for the three months ended March 31, 2008 compared to $1,692 during the three
months ended March 31, 2007.

                                        9
<PAGE>

Capital and Liquidity

The  Company had an  accumulated deficit  of $3,469,371 at  March 31, 2008
substantially all of which has been funded out of proceeds received from the
issuance of stock and the incurrence of losses.  As of March 31, 2008, the
Company had total assets of $375,293 and total liabilities of $61,544
resulting in a working capital surplus of $313,749.

The Company has borrowings under a note payable to NR Partners, a partnership
of which the President and one Director are the partners.  The NR note bears
interest at the  8.5  percent per annum (Note 6). The funds have been used for
general corporate purposes and  the outstanding  balance as  of May 1, 2008
is $18,520, due on or before July 31, 2008.  Regent GLSC raised $375,000
of capital through the sale of 75,000 shares of its Series A Preferred Stock,
which monies were used to purchase 192,678 shares of MacuCLEAR Preferred
Stock.  In addition, Regent GLSC has generated cash and earnings in the
amounts of $250,000 and $76,581, respectively, through the sale of part of
its holdings of MacuCLEAR Preferred Stock (Note 3).

As of the date of this quarterly report, there is substantial doubt regarding
our ability to continue as a going concern as we have not generated sufficient
cash flow to fund our business operations and material commitments. Our future
success and  viability, therefore, are  dependent  upon our ability to generate
capital financing.  We are  optimistic  that we will be  successful in  our new
business  operations  and  capital  raising  efforts; however,  there can be no
assurance that we will be successful in generating revenue or raising additional
capital. The failure to generate sufficient revenues or raise additional capital
may have a material and adverse effect upon the Company and our shareholders.

The Company is not performing any product research and development at this time
and it is not expected to purchase equipment or incur significant changes in the
number of employees.

Off-Balance Sheet Arrangements

As of the date of this report, we do not have any off-balance sheet arrangements
that have or are reasonably likely  to have a current or future effect on our
financial condition, changes in  financial  condition,  revenues or  expenses,
results of operations, liquidity, capital expenditures or capital resources that
are material to investors.  The term "off-balance sheet arrangement" generally
means any transaction, agreement or other contractual arrangement to which an
entity  unconsolidated  with us is a  party, under which we have:  (i) any
obligation arising under a guarantee contract, derivative instrument or variable
interest; or (ii) a retained or contingent interest in assets transferred to
such entity or similar arrangement that serves as credit, liquidity or market
risk support for such assets.

ITEM 3 - CONTROLS AND PROCEDURES

(a)    Evaluation of disclosure controls and procedures.

The Company's principal executive and financial officers have conducted an
evaluation of the effectiveness of the Company's disclosure controls and
procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of
1934 as of the end of the period (the "Evaluation Date").  Based upon that
evaluation, the Company's principal executive and financial officers have
concluded that, as of the Evaluation Date, the Company's disclosure controls
and procedures were effective in ensuring that all material information
relating to the Company required to be filed in this quarterly report has been
made known to them in a timely manner.

(b)    Changes in internal controls.

There have been no significant changes made in the Company's internal controls
or in other factors that has or will likely materially affect internal controls
over financial reporting.


                                        10
<PAGE>

                                     PART II

ITEM 1 - LEGAL PROCEEDINGS

On November 2, 2005, W. T. Skip Leake initiated litigation in the 101st State
District Court of Dallas County against the Company and the Company's stock
transfer agent seeking a declaratory judgment for the release of 1,000,000
shares of the 7,331,504 shares which former management states were issued
without consideration.  The Company filed a counter-claim against 35
defendants for a declaratory judgment that all disputed shares are void for
lack of Director approval and failure of consideration and that the 7,331,504
shares should be cancelled.  On September 18, 2006, the Company reached a
settlement with W. T. Skip Leake, whereby he effectively agreed to return
900,000 shares.  As of December 31, 2007, 29 defendants had returned stock
certificates representing 12,362,840 shares and returned lost certificate
resolutions representing 2,771,832 shares, all of which have been cancelled.

Following the surrender of approximately 16,000,000 shares, the Company
filed a default judgment on one defendant and a dismissal of the lawsuit.
On May 16, 2008, the Company received notice that the default judgment had
been rendered in favor of the Company and the lawsuit was terminated.  The
default judgment declared an additional 120,000 shares of common stock of
the Company void and the shares will be cancelled.


ITEM 1A - RISK FACTORS

There have been no significant changes in the Company's risk factors as
outlined in the Company's Form 10-KSB for the period ending December 31, 2007.


ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following information relates to all securities issued or sold by us
during the period covered by this report and not registered under the
Securities Act of 1933. Each of the transactions described below was
conducted in reliance upon the available exemptions from the registration
requirements of the Securities Act of 1933 under Section 3(a)(9) of the
Securities Act of 1933. There were no underwriters employed in connection
with any of the transactions set forth herein:

On February 20, 2008, Regent GLSC sold 10,000 shares of Regent GLSC
Preferred Stock for $5.00 per share as the final sale under the initial
private placement offering for the sale of Regent GLSC Preferred Stock.
The proceeds were used for general corporate purposes.

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES

          None

ITEM 4 - SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

          None

ITEM 5 - OTHER INFORMATION

          None


                                        11
<PAGE>

ITEM 6 - EXHIBITS AND REPORTS ON FORM 8-K

(a) Exhibits

Exhibit                 Description of Exhibit
No.

3.1   Certificate of Incorporation.  Incorporated by reference to the Company's
      Registration Statement which became effective November 18, 1980 (File
      Number 2-69087).

3.2   Restated Articles of Incorporation of Regent Technologies, Inc.;
      Incorporated by references to  Regent Petroleum Corporation Proxy
      Statement for Special Meeting of Shareholders held January 26, 1988,
      dated December 30, 1987.

3.3   Bylaws of Regent Technologies, Inc. as amended; Incorporated by references
      to Regent Petroleum Corporation Proxy Statement for Special Meeting of
      Shareholders held January 26, 1988, dated December 30, 1987.

3.4   Code of Ethics; adopted by a resolution of the Board of Directors dated
      March 14, 2006 with an effective date of March 1, 2006.

4.1   Certificate of Designations of 2007 Series A Convertible Preferred Stock
      for Regent GLSC Technologies, Inc. approved April 7, 2007.

10.1  Restricted Stock Agreement granting Director stock awards approved
      on November 26, 2007.

21    List of subsidiaries - Regent GLSC Technologies, Inc.

31.1  Certification of Chief Executive Officer and Principal Accounting Officer

32.1  Certification of Chief Executive Officer and Principal Accounting Officer


(b) Reports filed on Form 8-K

    On January 14, 2008, the Company filed a Current Report on Form 8-K
    reporting that the Company had settled all outstanding claims regarding the
    litigation initiated in November, 2005 by W.T. Leake in the 101st State
    District Court of Dallas County against the Company and the stock transfer
    agent.  The Company further reported that it is seeking a default judgment
    for the cancellation of 120,000 shares of common stock and dismissing its
    counter-claim against 34 additional defendants following the surrender of
    15,692,338 shares for cancellation as void for lack of Director approval
    and failure of consideration.



                               SIGNATURE

In accordance with the requirements of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                      REGENT TECHNOLOGIES, INC.

Dated: May 20, 2008              By: /s/ David A. Nelson
                                      ---------------------------------------
                                      David A. Nelson, Chief Executive Officer,
                                      Principal Accounting Officer


                                        12